研究疾病:
|
单纯性肥胖
|
研究疾病代码:
|
|
Target disease:
|
Simple obesity
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
探索性研究/预试验
Pilot clinical trial
|
研究目的:
|
研究选取连续波、疏密波、断续波电针刺激腹部腧穴观察对单纯性肥胖患者在体重、BMI、腰围等方面的疗效。
|
Objectives of Study:
|
The study selected continuous wave, sparse wave, and intermittent wave electroacupuncture stimulation of abdominal acupoints to observe the therapeutic effects on weight, BMI, waist circumference, and other aspects of patients with simple obesity.
|
药物成份或治疗方案详述:
|
1 试验方案
1.1 取穴及操作
1.1.1 疏密波组
取穴:中脘、气海、大横、天枢、带脉
操作:患者取仰卧位,常规消毒,采用0.25×40mm无菌针灸针,直刺35-38mm,各穴得气后留针,选用华佗牌SDZ-Ⅱ型电针仪,电针一组连接中脘、气海穴,一组连接双侧带脉穴一组,选用疏密波,频率为2HZ,电流强度为5mA,留针30min。
1.1.2 连续波组
取穴:中脘、气海、大横、天枢、带脉
操作:患者取仰卧位,常规消毒,采用0.25×40mm无菌针灸针,直刺35-38mm,各穴得气后留针,选用华佗牌SDZ-Ⅱ型电针仪,电针一组连接中脘、气海穴,一组连接双侧带脉穴一组,选用连续波,频率为2HZ,电流强度为5mA,留针30min。
1.1.3 断续波组
取穴:中脘、气海、大横、天枢、带脉
操作:患者取仰卧位,常规消毒,采用0.25×40mm无菌针灸针,直刺35-38mm,各穴得气后留针,选用华佗牌SDZ-Ⅱ型电针仪,电针一组连接中脘、气海穴,一组连接双侧带脉穴一组,选用断续波,频率为2HZ,电流强度为5mA,留针30min。
1.2 腧穴定位
参考2006年中华人民共和国国家标准(GB/T 12346-2006)《腧穴名称与定位》。
中脘:在腹部,前正中线上,脐上4寸。
气海:在腹部,前正中线上,脐下1.5寸。
大横:在腹部,横平脐中,前正中线旁开4寸。
天枢:在腹部,横平脐中,前正中线旁开2寸。
带脉:在侧腹部,第十一肋骨游离端下方垂线与脐水平线的交点上。
1.3 治疗频次及疗程
隔日治疗1次,1周治疗3次,4周为1疗程,共治疗2个疗程。
1.4 针具选择
选用安迪牌一次性无菌不锈钢针灸针,规格为0.25×40mm。(购自贵州安迪药械有限公司,注册证号:黔食药监械(准)字2014第2270027号。)
|
Description for medicine or protocol of treatment in detail:
|
1 Experimental plan
1.1 Acupoint selection and operation
1.1.1 Dense wave group
Acupoint selection: Zhongwan, Qihai, Daheng, Tianshu, and Daimai
Operation.
1.1.2 Continuous wave group
Acupoint selection: Zhongwan, Qihai, Daheng, Tianshu, and Daimai
Operation.
1.1.3 Intermittent wave group
Acupoint selection: Zhongwan, Qihai, Daheng, Tianshu, and Daimai
Operation.
1.2 Acupoint positioning
Refer to the 2006 National Standard of the People's Republic of China (GB/T 12346-2006) "Acupoint Names and Localization".
Middle epigastric region: located in the abdomen, on the anterior midline, 4 inches above the navel.
Qi Sea: In the abdomen, on the anterior midline, 1.5 inches below the navel.
Large horizontal: in the abdomen, horizontally flat at the navel, with a 4-inch opening next to the midline.
Tian Shu: It is located in the abdomen, horizontally parallel to the navel, and 2 inches apart from the anterior midline.
Meridian: On the lateral abdomen, at the intersection of the vertical line below the free end of the eleventh rib and the horizontal line of the navel.
1.3 Treatment frequency and duration
Treat once every other day, three times a week, and four weeks as one course of treatment, for a total of two courses of treatment.
1.4 Needle selection
Andi brand disposable sterile stainless steel acupuncture and moxibustion needle with a specification of 0.25 × 40mm is selected. (Purchased from Guizhou Andi Pharmaceutical Equipment Co., Ltd., registration certificate number: Guizhou Food and Drug Supervision Equipment (Approval) No. 2014 2270027.)
|
纳入标准:
|
纳入标准
(1)符合上述单纯性肥胖的西医诊断标准;
(2)年龄20-55岁,性别不限;
(3)近3个月内未进行减肥相关治疗并且没有参加其他临床试验;
(4)根据临床资料明确可排除不是因其他疾病或药物所致的肥胖;
(5)自愿配合针刺治疗并签署知情同意书。
以上五条同时符合方可纳入。
|
Inclusion criteria
|
Inclusion criteria
(1) Meets the Western diagnostic criteria for simple obesity mentioned above;
(2) Age range: 20-55 years old, gender not limited;
(3) Not receiving weight loss related treatment within the past 3 months and not participating in other clinical trials;
(4) According to clinical data, obesity that is not caused by other diseases or drugs can be excluded;
(5) Voluntarily cooperate with acupuncture treatment and sign an informed consent form.
Only those who meet the above five criteria can be included.
|
排除标准:
|
排除标准
(1)下丘脑疾病、垂体疾病、甲状腺功能低下、药物等引起的继发性肥胖症;
(2)合并精神疾患,无法合作或不愿合作者;
(3)正处于怀孕期或者哺乳期的妇女;
(4)合并严重心血管疾病、脑血管疾病、肝肾功能不全、血液系统疾病、精神疾病;
(5)存在任何针灸的禁忌症,施针部位有伤痕或感染,或研究人员认为施针部位出现不适合采取措施的全身疾病;
(6)正在参加其他临床试验者。
符合上述任意一项者均不能入组。
|
Exclusion criteria:
|
Exclusion criteria
(1) Secondary obesity caused by hypothalamic diseases, pituitary diseases, hypothyroidism, medication, etc;
(2) Individuals with combined mental illnesses who are unable or unwilling to cooperate;
(3) Women who are currently pregnant or breastfeeding;
(4) Merge severe cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction, hematological disease, and mental illness;
(5) There are any contraindications of acupuncture and moxibustion, scars or infections at the application site, or the researchers think that there are systemic diseases at the application site that are not suitable for taking measures;
(6) Participants in other clinical trials.
Those who meet any of the above criteria cannot be included in the group.
|
研究实施时间:
Study execute time:
|
从From
2024-12-01
至To
2027-12-01
|
征募观察对象时间:
Recruiting time:
|
从From
2024-12-01
至To
2027-12-01
|